IVA - Inventiva S.A.
NASDAQ
->
Healthcare
->
Biotechnology
Daix,
France
Type: Equity
IVA price evolution
IVA
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Jun 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.21 | $26.92 | $31.24 | $86.74 |
| Short term investments | ||||
| Net receivables | $11.03 | $3.81 | $2.22 | $10.67 |
| Inventory | $0.39 | $0.42 | $0.4 | $0.37 |
| Total current assets | $28.61 | $48.19 | $52.37 | $106.38 |
| Long term investments | $1.43 | |||
| Property, plant & equipment | $7.98 | $9.13 | $7.51 | $7.38 |
| Goodwill & intangible assets | $0.54 | $0.66 | $0.57 | |
| Total noncurrent assets | $21.37 | $18.45 | $9.62 | |
| Total investments | $1.43 | |||
| Total assets | $39.43 | $69.56 | $70.82 | $116 |
| Current liabilities | ||||
| Accounts payable | $36.58 | $37.68 | $28.69 | $19.36 |
| Deferred revenue | $0.07 | $0.06 | $0.06 | |
| Short long term debt | $5.31 | $4.12 | $5.85 | |
| Total current liabilities | $48.15 | $50.16 | $37.8 | $30.7 |
| Long term debt | $46.85 | $48.77 | $39.27 | $38.54 |
| Total noncurrent liabilities | $51.43 | $40.69 | $39.83 | |
| Total debt | $54.08 | $43.39 | $44.39 | |
| Total liabilities | $118.49 | $101.59 | $78.49 | $70.53 |
| Shareholders' equity | ||||
| Retained earnings | -$281.44 | -$235.01 | -$181.81 | -$128.56 |
| Other shareholder equity | -$0 | $0.6 | -$0.17 | -$0.27 |
| Total shareholder equity | -$32.03 | -$7.67 | $45.48 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26.92 | $86.74 | $86.55 | $105.69 |
| Short term investments | ||||
| Net receivables | $3.81 | $10.67 | $4 | $0.05 |
| Inventory | $0.42 | $0.37 | $0.39 | $0.32 |
| Total current assets | $48.19 | $106.38 | $115.58 | $133 |
| Long term investments | $1.43 | |||
| Property, plant & equipment | $9.13 | $7.38 | $3.2 | $3.28 |
| Goodwill & intangible assets | $0.54 | $0.57 | $0.77 | $0.94 |
| Total noncurrent assets | $21.37 | $9.62 | $6.41 | $5.92 |
| Total investments | $1.43 | |||
| Total assets | $69.56 | $116 | $121.98 | $138.92 |
| Current liabilities | ||||
| Accounts payable | $37.68 | $19.36 | $14.6 | $6.92 |
| Deferred revenue | $0.07 | $0.06 | ||
| Short long term debt | $5.31 | $5.85 | $1.28 | $0.02 |
| Total current liabilities | $50.16 | $30.7 | $22.85 | $13.91 |
| Long term debt | $48.77 | $38.54 | $8.84 | $10.04 |
| Total noncurrent liabilities | $51.43 | $39.83 | $10.27 | $13.8 |
| Total debt | $54.08 | $44.39 | $10.12 | $10.05 |
| Total liabilities | $101.59 | $70.53 | $33.12 | $27.71 |
| Shareholders' equity | ||||
| Retained earnings | -$235.01 | -$128.56 | -$76.45 | -$28.84 |
| Other shareholder equity | $0.6 | -$0.27 | -$0.16 | $5.46 |
| Total shareholder equity | -$32.03 | $45.48 | $88.87 | $111.21 |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.04 | $15.58 | $1.9 | $12.18 |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $52.29 | $63.28 | $56.86 | $69.04 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.12 | $0.61 | -$0.01 | -$0.02 |
| Interest expense | $3.51 | -$3.22 | -$1.91 | $2.74 |
| Net income | ||||
| Net income | -$49.03 | -$55.16 | -$55.27 | -$54.27 |
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $23.16 | $18.81 | $8.5 | $5.26 |
| Cost of revenue | ||||
| Gross Profit | $23.16 | $18.81 | $8.5 | $5.26 |
| Operating activities | ||||
| Research & development | $110.01 | $60.47 | $48.45 | $23.72 |
| Selling, general & administrative | $15.82 | $15.49 | $11.52 | $9.06 |
| Total operating expenses | $125.87 | $75.92 | $60.62 | $34.98 |
| Operating income | -$102.71 | -$57.11 | -$52.11 | -$29.72 |
| Income from continuing operations | ||||
| EBIT | -$102.94 | -$52.19 | -$46.64 | -$27.66 |
| Income tax expense | $0.61 | -$0.02 | $0.36 | |
| Interest expense | $6.88 | $2.11 | $2.63 | $5.96 |
| Net income | ||||
| Net income | -$110.43 | -$54.27 | -$49.63 | -$33.62 |
| Income (for common shares) | -$110.43 | -$54.27 | -$49.63 | -$33.62 |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $8.91 | -$7.73 | -$7.7 | $8.87 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $22.57 | $29.08 | -$2.15 | $37.27 |
| Effect of exchange rate | $0.09 | $0.45 | -$0.41 | -$1.02 |
| Change in cash and equivalents | -$16.77 | -$59.82 | -$55.49 | $0.18 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$110.43 | -$54.27 | -$49.63 | -$33.62 |
| Operating activities | ||||
| Depreciation | $2.6 | $1.7 | -$1.29 | $1.89 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.97 | $2.22 | $2.09 | $0.94 |
| Total cash flows from operations | -$81.61 | -$44.93 | -$47.63 | -$30.59 |
| Investing activities | ||||
| Capital expenditures | -$0.41 | -$0.52 | -$0.45 | -$0.29 |
| Investments | $0.98 | $9.39 | -$1.3 | -$7.69 |
| Total cash flows from investing | -$7.73 | $8.87 | -$1.79 | -$8.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $28.08 | $8.83 | $25.48 | $101.78 |
| Net borrowings | $1 | $28.44 | -$0.03 | $9.89 |
| Total cash flows from financing | $29.08 | $37.27 | $25.45 | $111.67 |
| Effect of exchange rate | -$2.68 | |||
| Change in cash and equivalents | -$60.26 | $1.21 | -$23.98 | $72.53 |
News
Fundamentals
| Market cap | $364.74M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 52.86M |
| Revenue | $29.70M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$213.73M |
| Revenue Q/Q | -38.81% |
| Revenue Y/Y | N/A |
| P/E ratio | -1.71 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 12.28 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.02 |
| EPS | -$4.04 |
|---|---|
| ROA | -289.01% |
| ROE | N/A |
| Debt/Equity | -3.17 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.59 |
| Quick ratio | 0.59 |